Insulet Corp : Insulet reports fourth quarter and full year 2016 financial results . Q4 loss per share $0.16 from continuing operations . Q4 revenue $103.6 million versus I/B/E/S view $100.6 million . Q4 earnings per share view $-0.05 -- Thomson Reuters I/B/E/S . Sees FY 2017 revenue up about 17 percent . Sees FY 2017 revenue $420 million to $440 million .For quarter ending March 31, 2017, company expects to generate revenue in range of $96 to $99 million.
Adderacare AB : Q4 net sales 28.0 million Swedish crowns ($3.1 million)versus 24.1 million crowns year ago .Q4 EBITDA 3.5 million crowns versus 3.1 million crowns year ago.
Halyard Health Inc : Halyard health inc - s&ip net sales to kimberly-clark are expected to range between $40 and $45 million in 2017 . Halyard health, inc. Announces fourth quarter and full-year 2016 results, provides 2017 outlook . Sees fy 2017 adjusted earnings per share $1.70 to $2.00 . Q4 adjusted earnings per share $0.50 . Q4 earnings per share $0.21 . Q4 sales rose 2 percent to $410 million . Sees fy 2017 sales up 2 percent . Halyard health inc - we expect a foreign currency translation impact to net sales of 0 to down 2 percent in 2017 compared to prior year . Halyard health inc - company expects 2017 net sales, on a constant currency basis, to be even to up 2 percent compared to 2016 . Fy2017 earnings per share view $1.90, revenue view $1.58 billion -- Thomson Reuters I/B/E/S .Q4 earnings per share view $0.44, revenue view $401.7 million -- Thomson Reuters I/B/E/S.
Lepu Medical Technology Beijing Co Ltd <300003.SZ> :Says preliminary 2016 net profit up 31.2 percent y/y at 683.2 million yuan ($99.46 million).
JiangXi Sanxin Medtec Co Ltd <300453.SZ> : Sees net profit for Q1 FY 2017 to decrease by 0 percent to 29.9 percent, or to be 6.5 million yuan to 9.3 million yuan, compared to net profit of Q1 FY 2016 (9.3 million yuan) . Says increased cost and decreased sales as main reasons for the forecast .To use undistributed profits to pay a cash dividend of 1 yuan (pre-tax) per 10 shares to shareholders for 2016.
Techno Medical Pcl :FY profit for the year 26.9 million baht versus 28.8 million baht; FY total revenue 558.0 million baht versus 504.8 million baht.
Cytori Therapeutics Inc :Azaya Therapeutics Inc reports 5 percent passive stake in Cytori Therapeutics as on Feb. 15, 2017.
Intersect Ent Inc : Intersect ENT announces FDA approval of newest steroid releasing implant, Propel Contour, for use in treating the frontal and maxillary sinuses . Intersect ENT Inc - expects to launch propel contour broadly in Q2 of 2017 and maintains its previously stated 2017 revenue guidance of $87-$89 million .FY2017 revenue view $88.0 million -- Thomson Reuters I/B/E/S.
Vwr Corp : VWR Corp reports fourth quarter 2016 financial results . Projects 2017 net sales of $4.56 billion to $4.61 billion, up 1 pct to 2 pct, and up 3 pct to 4 pct on a constant-currency basis . Q4 sales $1.13 billion versus I/B/E/S view $1.15 billion . Q4 earnings per share view $0.44 -- Thomson Reuters I/B/E/S . Sees FY 2017 sales $4.56 billion to $4.61 billion . Q4 adjusted earnings per share $0.45 . Sees FY 2017 sales up 1 to 2 percent . Sees 2017 adjusted eps of $1.79 to $1.87, up 4 pct to 9 pct, and up 6 pct to 11 pct on a constant-currency basis .Fy2017 earnings per share view $1.79, revenue view $4.65 billion -- Thomson Reuters I/B/E/S.